Your session is about to expire
← Back to Search
Lisdexamfetamine for Post-Bariatric Surgery Weight Control
Study Summary
This trial will test whether lisdexamfetamine can help people with uncontrolled eating and weight issues after bariatric surgery, when other treatments haven't worked.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a severe kidney, liver, nerve, lung condition, or another serious health issue.My blood pressure is high and not under control.You have a history of eating disorders like anorexia or bulimia.I am allergic to LDX or similar stimulant medications.My current medication cannot be combined with the study drug.I am currently taking medication for ADHD or using psychostimulants.My blood pressure or heart rate is higher than normal and untreated.I started losing control over my eating 6 months after weight loss surgery and didn't improve with 4 months of treatment.I have a history or risk of seizures due to various health conditions or family history.My diabetes is not currently under control.You have had a problem with alcohol or drugs in the past or currently. Smoking is not a reason for exclusion.My thyroid is underactive and not yet treated, confirmed by two tests.You have thoughts or plans about hurting yourself or someone else.I am currently receiving treatment for an eating disorder or to lose weight.You have a mental health condition that requires more intense treatment, like hospitalization, for conditions such as bipolar disorder, psychosis, or severe depression.I am currently taking MAOI, SSRI, or strong CYP2D6 inhibitors.I have gallbladder disease.I have a history of heart disease, arrhythmias needing medication, or stroke.I have had weight loss surgery, either gastric bypass or sleeve gastrectomy.I am currently taking medication to lose weight.I am between 18 and 64 years old.It has been about 10 months since my surgery.I have had issues with LDX or similar medications before.
- Group 1: Lisdexamfetamine dimesylate
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is Lisdexamfetamine Dimesylate (Medication) a new medication?
"There are currently 6 clinical trials studying the effects of Lisdexamfetamine Dimesylate (Medication), 3 of which have reached Phase 3. Most of these studies are taking place in Iowa City, although there are a total of six locations running trials for this medication."
To whom does this study's inclusion criteria apply?
"This trial is looking for 60 individuals that have experienced loss of control eating and meet the following age, surgery, and health requirements: 18-64 years old, laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy surgery ten months prior, regular loss of control eating six months after bariatric surgery, treatment nonresponders to a four-month medication and/or BWL trial. Lastly, participants must be available for 15 months and provide written informed consent."
Does this trial have open slots for participants?
"Unfortunately, this trial is not currently open to recruitment. Although the study was posted on 1/2/2022 and updated as recently as 10/4/2022, there are no plans to recruit patients at this time. However, there are 344 other studies concerning loss of control eating and 6 Lisdexamfetamine Dimesylate (Medication) trials that are actively recruiting participants."
Are there a lot of people involved in this experiment?
"At the moment, this trial is not looking for new participants. The listing was first put up on January 2nd, 2022 and has been edited most recently on October 4th, 2022. For other trials, there are currently 344 that are recruiting patients with loss of control eating and 6 for Lisdexamfetamine Dimesylate (Medication)."
Share this study with friends
Copy Link
Messenger